Literature DB >> 10840175

Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism.

J L Ingram1, S M Peckham, B Tisdale, P M Rodier.   

Abstract

Abnormalities in anatomy and function of the cranial nerve motor nuclei have been demonstrated in some people with autism and can be modeled in rats by exposure to valproic acid during neural tube closure. Reductions in Purkinje cell number and cerebellar volume, particularly of the posterior lobe, have also been reported in people with autism. Thus, a stereological examination of cerebellar morphology was undertaken in valproate-exposed rats. Compared to controls, rats exposed to a single dose of 600-mg/kg sodium valproate on embryonic day 12.5 had significantly fewer Purkinje cells in the cerebellar vermis and a reduction short of significant in the hemispheres. The diminished cell numbers reflect reductions in tissue volume throughout the cerebellum, rather than cell density, which was unaffected in all regions. Within the vermis, the reduction in volume was significantly greater in the posterior lobe than in the anterior lobe. The results parallel those reported for human cases of autism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840175     DOI: 10.1016/s0892-0362(99)00083-5

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  91 in total

Review 1.  Developmental neuropathology of environmental agents.

Authors:  Lucio G Costa; Michael Aschner; Annabella Vitalone; Tore Syversen; Offie Porat Soldin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Sensory and motor characterization in the postnatal valproate rat model of autism.

Authors:  Stacey Reynolds; Alexandre Millette; Darragh P Devine
Journal:  Dev Neurosci       Date:  2012-05-24       Impact factor: 2.984

3.  Prenatal effects of antiepileptic drugs.

Authors:  Chrysanthy Ikonomidou
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

4.  Exposure to Sodium Valproate during Pregnancy: Facial Features and Signs of Autism.

Authors:  Rachel Stadelmaier; Hanah Nasri; Curtis K Deutsch; Margaret Bauman; Anne Hunt; Christopher J Stodgell; Jane Adams; Lewis B Holmes
Journal:  Birth Defects Res       Date:  2017-06-21       Impact factor: 2.344

5.  Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.

Authors:  Tania Rinaldi; Karina Kulangara; Katia Antoniello; Henry Markram
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

6.  Altered expression of circadian rhythm and extracellular matrix genes in the medial prefrontal cortex of a valproic acid rat model of autism.

Authors:  Nikkie F M Olde Loohuis; Gerard J M Martens; Hans van Bokhoven; Barry B Kaplan; Judith R Homberg; Armaz Aschrafi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-10       Impact factor: 5.067

7.  Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism.

Authors:  Natalia V Malkova; Collin Z Yu; Elaine Y Hsiao; Marlyn J Moore; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2012-01-30       Impact factor: 7.217

Review 8.  Autism: an emerging public health problem.

Authors:  Craig J Newschaffer; Laura Kresch Curran
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

Review 9.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

10.  Maternal Exposure to Valproic Acid Primarily Targets Interneurons Followed by Late Effects on Neurogenesis in the Hippocampal Dentate Gyrus in Rat Offspring.

Authors:  Yousuke Watanabe; Tomoaki Murakami; Masashi Kawashima; Yasuko Hasegawa-Baba; Sayaka Mizukami; Nobuya Imatanaka; Yumi Akahori; Toshinori Yoshida; Makoto Shibutani
Journal:  Neurotox Res       Date:  2016-08-26       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.